Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271980 · ClinicalTrials.gov registry record
Early-Onset Colorectal Cancer Recurrence
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 177
- Enrollment target
NCT06271980 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 177 participants.
The verdict
NCT06271980 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
Survivors of early-onset colorectal cancer (diagnosed before age 50) may experience colorectal cancer recurrence several years after curative-intent treatments, but clinical guidelines provide unclear guidance on endoscopic surveillance. This study aims to predict recurrence-free survival and overall survival, in survivors of early-onset colorectal cancer, using a tumor-based molecular assay based on microRNA (ribonucleic acid)
Interventions
- OTHER ENCORE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2023-04-15 |
| Est. Completion | 2024-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06271980
The ClinicalTrials.gov registry entry for NCT06271980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ENCORE is the first listed.
NCT06271980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06271980 about?
NCT06271980 is a clinical study titled "Early-Onset Colorectal Cancer Recurrence". Survivors of early-onset colorectal cancer (diagnosed before age 50) may experience colorectal cancer recurrence several years after curative-intent treatments, but clinical guidelines provide unclear guidance on endoscopic surveillance. This study aims to predict recurrence-free survival and overa...
What is the current status of trial NCT06271980?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2023-04-15. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT06271980?
The interventions under investigation include: ENCORE (OTHER).
Who is sponsoring clinical trial NCT06271980?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.